Oxford microscopy company appoints veteran health tech developer as CTO

ONI Tyler Ralston

ONI, a rapidly growing microscopy company which has developed its Nanoimager platform that enables imaging of individual molecules in living cells, has appointed Tyler Ralston, PhD as Chief Technology Officer (CTO).

In this role, Dr. Ralston will provide leadership, strategic vision and oversee the research and development for advancing ONI’s technology. ONI has developed and started commercialising transformative single molecule microscopy that have significant impact on scientific discoveries in the emerging area of extracellular vesicles research as well as applied markets, such as immuno-oncology and virus detection.

ONI was founded in 2016 by Bo Jing and Achillefs Kapanidis. A spin-out from Oxford University, it is now a leading and rapidly growing biotech redefining the boundaries of scientific discovery with super-resolution microscopy.

Bo Jing, CEO of ONI, said: “We are delighted to welcome Tyler to the ONI team. He has a unique track record of inventing breakthrough technologies and integrating them into products with great user experience so that they become accessible for everyone. Tyler’s and ONI’s vision for the future is perfectly aligned and the team is very much looking forward to working with him to pioneer innovations that will enable incredible biomedical discoveries and applications for our customers.”

Dr. Ralston joins ONI from the USA-based 4Catalyzer incubator, where he most recently served as CTO for Tesseract. Over his tenure at 4Catalyzer, Dr. Ralston was the co-founder and helped lead the development for many technologies, including the Butterfly Network (NYSE: BFLY) Ultrasound-on-Chip technology, the Hyperfine Research portable MRI system and Tesseract iC ophthalmic imaging system. Dr. Ralston also brings rich technical experience from Lawrence Livermore National Laboratory and Massachusetts Institute of Technology Lincoln Laboratory, where he helped develop and advance programs in optical and radar imaging systems.  He has over 100 patents and received a PhD from University of Illinois-Urbana Champaign.

“ONI is a truly innovative company,” said Dr Ralston. “I am absolutely thrilled to be joining such a revolutionary, high-growth company and team with a mission for advancing so many impactful applications.  I look forward to working with the ONI team and to further build out the amazing technology and applications.”